Clinical trial
Comparison of Spexin and Phoenixin-20 Levels in Girls With Central Precocious Puberty, Premature Thelarche, and Healthy Controls
NCT07359092 is registered in ClinicalTrials.gov with Kayseri City Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Spexin and Phoenixin-20 Levels in Girls With Central Precocious Puberty, Premature Thelarche, and Healthy Controls
- Lead sponsor
- Kayseri City Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2024
- Completion date
- January 1, 2026
- Enrollment
- 143 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
central precocious puberty (cpp), hypothalamic-pituitary-ovarian axis dysfunction (disorder), puberty, puberty disorders